Synopsis
As part of this capital raise, Nazara’s stake in Nodwin will fall below 50%, officially changing its classification from a subsidiary to an associate company.

The capital infusion, which does not involve any sale of shares by Nazara, will dilute its stake in Nodwin below 50%, resulting in the reclassification of Nodwin from a subsidiary to an associate company. Despite the move, Nazara will remain Nodwin’s single largest shareholder
Elevate your knowledge and leadership skills at a cost cheaper than your daily tea.
Subscribe Now